13.55
1.16%
+0.1561
전일 마감가:
$13.39
열려 있는:
$13.38
하루 거래량:
711.33K
시가총액:
$3.75B
수익:
-
순이익/손실:
$-444.04M
주가수익비율:
-6.0474
EPS:
-2.24
순현금흐름:
$-384.11M
1주 성능:
+5.16%
1개월 성능:
+2.46%
6개월 성능:
+242.91%
1년 성능:
+84.04%
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
명칭
Iovance Biotherapeutics Inc
전화
650-260-7120
주소
999 Skyway Road, Suite 150, San Carlos
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-11-20 | 개시 | Goldman | Buy |
2023-09-18 | 재확인 | Barclays | Overweight |
2023-05-30 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2023-03-27 | 재개 | Wells Fargo | Equal Weight |
2023-01-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-12-09 | 다운그레이드 | Goldman | Buy → Neutral |
2022-10-31 | 개시 | Guggenheim | Neutral |
2022-08-18 | 재개 | Wells Fargo | Equal Weight |
2022-01-28 | 업그레이드 | Stifel | Hold → Buy |
2021-12-07 | 재개 | Cowen | Outperform |
2021-06-10 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
2021-05-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-05-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
2021-05-19 | 다운그레이드 | Stifel | Buy → Hold |
2021-05-03 | 개시 | Truist | Buy |
2021-04-16 | 개시 | Goldman | Buy |
2021-03-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2020-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2020-10-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-04-22 | 개시 | Mizuho | Buy |
2020-03-04 | 개시 | Barclays | Overweight |
2020-02-26 | 재확인 | H.C. Wainwright | Buy |
2020-02-26 | 재확인 | Oppenheimer | Outperform |
2019-12-18 | 개시 | JMP Securities | Mkt Outperform |
2019-10-01 | 개시 | Stifel | Buy |
2019-04-29 | 개시 | Piper Jaffray | Overweight |
2019-02-28 | 재확인 | Chardan Capital Markets | Buy |
2019-02-07 | 개시 | Robert W. Baird | Outperform |
2018-12-31 | 재개 | B. Riley FBR | Buy |
2018-07-06 | 재확인 | Chardan Capital Markets | Buy |
2018-04-10 | 업그레이드 | B. Riley FBR, Inc. | Neutral → Buy |
2018-03-13 | 재확인 | B. Riley FBR, Inc. | Neutral |
2018-02-23 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
2018-01-25 | 재확인 | H.C. Wainwright | Buy |
2017-11-01 | 재확인 | B. Riley FBR, Inc. | Buy |
모두보기
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks Investment Research
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks Investment Research
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
The Motley Fool
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
GlobeNewswire Inc.
Iovance Biotherapeutics to Present at Upcoming Conferences
GlobeNewswire Inc.
Where Will Iovance Biotherapeutics Stock Be in 5 Years?
The Motley Fool
Iovance Biotherapeutics Inc (IOVA) 재무 분석
Iovance Biotherapeutics Inc (IOVA) 순이익 2024
IOVA은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -444.04M 달러로 보고했으며, 전년대비 -12.16% 감소했습니다.
Iovance Biotherapeutics Inc (IOVA) 현금흐름 2024
2023-12-31 종료 분기에 IOVA은 현금흐름(지난 12개월)으로 -384.11M 달러를 기록했으며, 전년 대비 -22.65% 감소했습니다.
Iovance Biotherapeutics Inc (IOVA) 주당 순이익 2024
IOVA이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -1.88달러이며, 전년 대비 +24.19% 성장했습니다.
Iovance Biotherapeutics Inc 주식 (IOVA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer |
Apr 15 '24 |
Option Exercise |
0.00 |
2,812 |
0 |
43,989 |
BILINSKY IGOR | Chief Operating Officer |
Apr 15 '24 |
Option Exercise |
0.00 |
2,812 |
0 |
39,453 |
GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer |
Mar 04 '24 |
Option Exercise |
0.00 |
15,623 |
0 |
49,230 |
Vogt Frederick G | Interim CEO & General Counsel |
Mar 04 '24 |
Option Exercise |
0.00 |
41,662 |
0 |
140,800 |
Rothbaum Wayne P. | Director |
Feb 20 '24 |
Buy |
9.15 |
5,000,000 |
45,750,000 |
28,067,333 |
MCPEAK MERRILL A | Director |
Feb 20 '24 |
Buy |
9.15 |
250,000 |
2,287,500 |
320,150 |
Dukes Iain D. | Director |
Feb 20 '24 |
Buy |
9.15 |
32,000 |
292,800 |
54,000 |
Vogt Frederick G | Interim CEO & General Counsel |
Jan 16 '24 |
Option Exercise |
0.00 |
20,834 |
0 |
105,668 |
GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer |
Jan 16 '24 |
Option Exercise |
0.00 |
2,813 |
0 |
35,184 |
BILINSKY IGOR | Chief Operating Officer |
Jan 16 '24 |
Option Exercise |
0.00 |
2,813 |
0 |
31,444 |
자본화:
|
볼륨(24시간):